###begin article-title 0
###xml 54 62 <span type="species:ncbi:9606">Patients</span>
Serum Vascular Endothelial Growth Factor in Pediatric Patients with Community-Acquired Pneumonia and Pleural Effusion
###end article-title 0
###begin p 1
###xml 745 746 745 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1046 1058 1046 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumonia</italic>
###xml 86 94 <span type="species:ncbi:9606">children</span>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
###xml 663 671 <span type="species:ncbi:9606">children</span>
###xml 754 762 <span type="species:ncbi:9606">Children</span>
###xml 863 871 <span type="species:ncbi:9606">children</span>
###xml 916 924 <span type="species:ncbi:9606">children</span>
###xml 1013 1021 <span type="species:ncbi:9606">Children</span>
###xml 1204 1212 <span type="species:ncbi:9606">children</span>
###xml 1348 1356 <span type="species:ncbi:9606">children</span>
This study investigated the serum vascular endothelial growth factor (VEGF) levels in children with community-acquired pneumonia. Serum VEGF levels were measured in patients with pneumonia (n=29) and in control subjects (n=27) by a sandwich enzyme-linked immunosorbent assay. The pneumonia group was classified into bronchopneumonia with pleural effusion (n=1), bronchopneumonia without pleural effusion (n=15), lobar pneumonia with pleural effusion (n=4), and lobar pneumonia without pleural effusion (n=9) groups based on the findings of chest radiographs. We also measured serum IL-6 levels and the other acute inflammatory parameters. Serum levels of VEGF in children with pneumonia were significantly higher than those in control subjects (p<0.01). Children with lobar pneumonia with or without effusion showed significantly higher levels of serum VEGF than children with bronchopneumonia. For lobar pneumonia, children with pleural effusion showed higher levels of VEGF than those without pleural effusion. Children with a positive urinary S. pneumonia antigen test also showed higher levels of VEGF than those with a negative result. Serum IL-6 levels did not show significant differences between children with pneumonia and control subjects. Serum levels of VEGF showed a positive correlation with the erythrocyte sedimentation rate in the children with pneumonia. In conclusion, VEGF may be one of the key mediators that lead to lobar pneumonia and parapneumonic effusion.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 152 176 152 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 528 541 528 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 85 93 <span type="species:ncbi:9606">children</span>
###xml 152 176 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 208 216 <span type="species:ncbi:9606">children</span>
###xml 391 399 <span type="species:ncbi:9606">children</span>
###xml 489 497 <span type="species:ncbi:9606">patients</span>
###xml 528 541 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 620 628 <span type="species:ncbi:9606">children</span>
Community-acquired pneumonia (CAP) is one of the most common respiratory diseases in children and it represents a frequent cause of hospital admission. Streptococcus pneumoniae is the leading cause of CAP in children aged 3 weeks to 5 yr, and it is the major pathogen leading to complicated pneumonia such as parapneumonic effusion and empyema (1). Pleural effusion occasionally develops in children with community-acquired bacterial pneumonia and this can be diagnosed in about 40-50% of patients with bacterial pneumonia (2). S. pneumoniae is the leading etiologic agent associated with parapneumonic effusions in the children for whom an etiologic agent was recovered. Despite of its prevalence, there is only limited consensus about its pathogenesis due to the lack of available evidence-based data. Increased vascular permeability and leakage may play an important role in the development of exudative pleural effusions.
###end p 3
###begin p 4
###xml 209 210 209 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 211 212 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 328 329 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 440 441 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 442 443 442 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 724 726 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 534 542 <span type="species:ncbi:9606">patients</span>
###xml 895 903 <span type="species:ncbi:9606">patients</span>
Vascular endothelial growth factor (VEGF) is a dimeric 46-kDa protein, and it is an endothelial, cell-specific, multifunctional cytokine that plays an important role in angiogenesis and vascular permeability (3-5). VEGF has been postulated to be an important mediator in the formation of malignant pleural and peritoneal fluid (6). VEGF levels are also known to be elevated in chronic pulmonary diseases such as asthma and cystic fibrosis (7-9). It has recently been reported that serum VEGF levels are significantly increased in the patients with active pulmonary tuberculosis and these levels are decreased after successful treatment (10). However in regard to pneumonia, only a few cases have been reported on so far (11,12), and there has been no data about CAP as classified on the basis of the radiologic type and etiology. Therefore, we investigated the serum levels of VEGF in pediatric patients with CAP according to its radiologic type and etiology to see if the serum VEGF levels are related to the pathogenesis of severe, complicated pneumonia.
###end p 4
###begin title 5
MATERIALS AND METHODS
###end title 5
###begin title 6
Study groups
###end title 6
###begin p 7
###xml 36 44 <span type="species:ncbi:9606">children</span>
###xml 58 62 <span type="species:ncbi:9606">boys</span>
###xml 70 75 <span type="species:ncbi:9606">girls</span>
###xml 148 156 <span type="species:ncbi:9606">children</span>
###xml 206 214 <span type="species:ncbi:9606">children</span>
###xml 337 345 <span type="species:ncbi:9606">Patients</span>
###xml 561 569 <span type="species:ncbi:9606">children</span>
From 1 May 2003 to 30 June 2004, 29 children with CAP (11 boys and 18 girls aged from 4 to 168 months; mean age: 52 months) and 27 afebrile healthy children were prospectively recruited for this study. The children with CAP had acute respiratory symptoms with fever (temperature >/=38.0â„ƒ) and new infiltrates on their chest radiographs. Patients were excluded from the study if any of the following criteria were found: the presence of malignancy, immunodeficiency or congestive heart disease; the presence of an alternative diagnosis during the follow-up; the children had been hospitalized in the preceding 72 hr.
###end p 7
###begin p 8
###xml 68 75 <span type="species:ncbi:9606">patient</span>
###xml 124 131 <span type="species:ncbi:9606">patient</span>
###xml 226 234 <span type="species:ncbi:9606">patients</span>
###xml 526 534 <span type="species:ncbi:9606">children</span>
###xml 646 650 <span type="species:ncbi:9606">boys</span>
###xml 658 663 <span type="species:ncbi:9606">girls</span>
Parapneumonic effusion was evaluated with chest radiographs and the patient was excluded from the study if the cause of the patient's illness was identified as other than pneumonia, or if the pleural fluid was transudate. The patients were classified into bronchopneumonia with pleural effusion (n=1), bronchopneumonia without pleural effusion (n=15), lobar pneumonia (focal consolidation was considered as lobar pneumonia) with pleural effusion (n=4), and lobar pneumonia without pleural effusion (n=9). Twenty seven healthy children who visited hospital for routine checks and had no respiratory symptoms were enrolled as the control group (13 boys and 14 girls; age range: 80-132 months; mean age: 119 months). The study design was approved by the ethics committee of the hospital and an informed consent was obtained from all the parents.
###end p 8
###begin title 9
Microbiological investigations
###end title 9
###begin p 10
###xml 100 124 100 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcal pneumoniae</italic>
###xml 167 188 167 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycoplasma pneumoniae</italic>
###xml 167 188 <span type="species:ncbi:2104">Mycoplasma pneumoniae</span>
###xml 243 251 <span type="species:ncbi:9606">patients</span>
To identify the causative organisms, we performed blood and/or pleural fluid culture, rapid urinary Streptococcal pneumoniae antigen test and detection of antibody to Mycoplasma pneumoniae. Pleural fluid was obtained by thoracentesis from the patients with parapneumonic effusion. Pleural fluid was investigated for biochemistry, the leukocyte count, Gram's stain and culture for aerobic and anaerobic bacteria. Exudate was defined by the ratio of the protein in pleural fluid/serum >0.5 and the ratio of LDH in the pleural fluid/serum >0.6. We did not perform culture, polymerase chain reaction or serologic investigations for virus.
###end p 10
###begin p 11
###xml 52 65 52 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 111 124 111 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 153 156 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 399 420 397 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycoplasma pneumoniae</italic>
###xml 52 65 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 111 124 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 296 301 <span type="species:ncbi:9606">human</span>
###xml 399 420 <span type="species:ncbi:2104">Mycoplasma pneumoniae</span>
The urine samples were analysed for the presence of S. pneumoniae cell-wall antigen with using the rapid urine S. pneumoniae antigen assay kit (Binax NOW(R), Portland, ME, U.S.A.). This test device contains an immunochromatographic membrane that is used to detect soluble pneumococcal antigen in human urine. Blood samples were drawn on days 1 and 14 of treatment for the detection of antibodies to Mycoplasma pneumoniae, and the infection was defined as mycoplasma pneumonia when a fourfold increase of the antibody titer was detected during the convalescent period.
###end p 11
###begin title 12
Measurement of VEGF and IL-6
###end title 12
###begin p 13
On the first day of admission, venous blood was drawn and centrifuged at 300xg for 10 min at 4â„ƒ. The samples were stored at -70â„ƒ until the measurements of VEGF and IL-6 at -70â„ƒ until the measurements of VEGF and IL-6 were performed with using enzyme linked immunosorbent assay kits (R&D Systems, Minneapolis, MN, U.S.A.).
###end p 13
###begin p 14
###xml 283 294 <span type="species:ncbi:3704">horseradish</span>
###xml 562 567 <span type="species:ncbi:9606">human</span>
In brief, 200microL of the cell supernatant was incubated with 50microL of assay diluent for 2 hr at room temperature in a 96- well plate coated with a monoclonal antibody against VEGF or IL-6. After three washes, a conjugate that consisted of a polyclonal VEGF or IL-6 antibody and horseradish peroxidase was then added, and this was allowed to incubate for 2 hr at room temperature. After addition of a color reagent, the absorbance was measured at a wavelength of 450 nm in a Thermo-Max microplate reader. For standardization, serial dilutions of recombinant human VEGF or IL-6 were assayed at the same time. The detection limit was 3.12 pg/mL for IL-6 and 31.2 pg/mL for VEGF.
###end p 14
###begin p 15
Tests for the complete blood cell count, the erythrocyte sedimentation rate (ESR), and the C-reactive protein (CRP) levels were performed at the same time.
###end p 15
###begin title 16
Statistical analysis
###end title 16
###begin p 17
###xml 273 274 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The results were expressed as means+/-standard error of the mean. All the statistics were performed by using the SPSS version 11.0 software program. Comparison of the VEGF and IL-6 concentrations between the study groups were analyzed by the Mann-Whitney rank sum test and p values <0.05 were considered as significant. The correlations were determined by Spearman rank correlation test.
###end p 17
###begin title 18
RESULTS
###end title 18
###begin title 19
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient characteristics
###end title 19
###begin p 20
###xml 62 69 62 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 36 44 <span type="species:ncbi:9606">children</span>
###xml 85 93 <span type="species:ncbi:9606">children</span>
###xml 124 132 <span type="species:ncbi:9606">children</span>
###xml 194 202 <span type="species:ncbi:9606">children</span>
###xml 290 298 <span type="species:ncbi:9606">patients</span>
###xml 342 349 <span type="species:ncbi:9606">patient</span>
The characteristics of the enrolled children are presented in Table 1. Out of the 29 children with pneumonia, there were 16 children with bronchopneumonia (1 with parapneumonic effusion) and 13 children with lobar pneumonia (4 with parapneumonic effusion). Thoracentesis was performed in 4 patients with parapneumonic effusion except for one patient with bronchopneumonia who had only a scanty amount of fluid. All the pleural fluids were confirmed as exudates.
###end p 20
###begin p 21
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 319 327 <span type="species:ncbi:9606">patients</span>
###xml 517 525 <span type="species:ncbi:9606">patients</span>
###xml 579 587 <span type="species:ncbi:9606">patients</span>
###xml 636 644 <span type="species:ncbi:9606">patients</span>
###xml 759 767 <span type="species:ncbi:9606">patients</span>
###xml 887 895 <span type="species:ncbi:9606">patients</span>
###xml 952 960 <span type="species:ncbi:9606">patients</span>
The mean age of the control group was higher compared to the pneumonia groups. However, age did not influence the serum VEGF concentrations. Neither our previous study (13) nor this study showed any correlations between serum VEGF levels and the subjects' age in control groups. The mean white blood cell counts in the patients with pneumonia were higher than those in the control subjects, but showed no differences among the pneumonia groups. The mean level of C-reactive protein was significantly increased in the patients having lobar pneumonia with effusion compared to the patients having lobar pneumonia without effusion and the patients having bronchopneumonia with effusion. The mean erythrocyte sedimentation rate was significantly increased in the patients having lobar pneumonia with effusion compared to the other groups, and the ESR was also significantly increased in the patients having lobar pneumonia without effusion compared to the patients having bronchopneumonia with effusion.
###end p 21
###begin p 22
###xml 12 36 12 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 12 36 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
###xml 143 151 <span type="species:ncbi:9606">patients</span>
###xml 192 200 <span type="species:ncbi:9606">patients</span>
###xml 228 236 <span type="species:ncbi:9606">patients</span>
The urinary Streptococcus pneumoniae antigen test was positive in 5 of 13 patients with lobar pneumonia, and this test was negative in all the patients with bronchopneumonia. Among those five patients with positive tests, three patients had parapneumonic effusions. There were no culture-confirmed cases.
###end p 22
###begin p 23
###xml 13 21 <span type="species:ncbi:9606">patients</span>
###xml 91 99 <span type="species:ncbi:9606">patients</span>
###xml 145 153 <span type="species:ncbi:9606">patients</span>
There were 8 patients with mycoplasma pneumonia. Four of them had bronchopneumonia and two patients had lobar pneumonia without effusion and two patients had lobar pneumonia with effusion. The serum levels of IL-6 showed no significant differences among the pneumonia groups.
###end p 23
###begin title 24
Serum VEGF and IL-6 levels according to the radiologic types of pneumonia and the etiologies
###end title 24
###begin p 25
###xml 186 187 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 393 394 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 402 408 394 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 69 77 <span type="species:ncbi:9606">patients</span>
###xml 231 239 <span type="species:ncbi:9606">patients</span>
###xml 339 347 <span type="species:ncbi:9606">patients</span>
The mean concentration of serum VEGF was 669.42+/-85.28 pg/mL in the patients with pneumonia, and this was significantly increased compared to the control subjects (110.23+/-4.77 pg/mL, p<0.01). The mean level of serum VEGF in the patients with lobar pneumonia was 987.95+/-133.10 pg/mL, and this was significantly higher than that in the patients with bronchopneumonia (410.62+/-55.96 pg/mL, p<0.01) (Fig. 1).
###end p 25
###begin p 26
###xml 219 220 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 346 359 342 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 498 499 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 508 514 500 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 7 15 <span type="species:ncbi:9606">patients</span>
###xml 161 169 <span type="species:ncbi:9606">patients</span>
###xml 246 254 <span type="species:ncbi:9606">patients</span>
###xml 315 323 <span type="species:ncbi:9606">patients</span>
###xml 346 359 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 443 451 <span type="species:ncbi:9606">patients</span>
###xml 525 533 <span type="species:ncbi:9606">patients</span>
###xml 659 667 <span type="species:ncbi:9606">patients</span>
In the patients with lobar pneumonia, the serum VEGF levels of those with pleural effusion (1432.48+/-242.94 pg/mL) were also significantly higher than in those patients without pleural effusion (790.37+/-122.63 pg/mL, p=0.021). Likewise, in the patients with lobar pneumonia, the mean level of serum VEGF in those patients with a positive urine S. pneumoniae antigen test (1153.73+/-95.35 pg/mL) was significantly increased compared to those patients with negative results (702.06+/-172.15 pg/mL, p=0.047) (Fig. 2). For the patients with mycoplasma pneumonia, they did not show any significant differences in the serum VEGF and IL-6 levels compared to those patients without mycoplasma pneumonia (data not shown).
###end p 26
###begin p 27
###xml 299 312 299 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 472 473 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 547 553 547 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
###xml 145 153 <span type="species:ncbi:9606">patients</span>
###xml 299 312 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 376 384 <span type="species:ncbi:9606">patients</span>
For the serum IL-6 levels, there were no significant differences between the patients with bronchopneumonia and lobar pneumonia, and between the patients with effusion and without effusion, and nor were there significant differences between the subjects who were positive or negative on the urinary S. pneumoniae antigen test (data not shown). The serum levels of VEGF in the patients with pneumonia showed positive correlation with their erythrocyte sedimentation rates (p=0.024), but there was no correlation with the serum IL-6 and CRP levels (Fig. 3). The white blood cell counts and the duration of fever showed no correlations with the serum VEGF levels (data not shown).
###end p 27
###begin title 28
DISCUSSION
###end title 28
###begin p 29
###xml 406 407 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 408 409 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1068 1070 1068 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1405 1407 1405 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 92 100 <span type="species:ncbi:9606">children</span>
###xml 141 149 <span type="species:ncbi:9606">children</span>
###xml 676 684 <span type="species:ncbi:9606">patients</span>
###xml 974 982 <span type="species:ncbi:9606">patients</span>
###xml 1269 1277 <span type="species:ncbi:9606">patients</span>
###xml 1362 1370 <span type="species:ncbi:9606">patients</span>
In this study, we have demonstrated that the serum VEGF concentrations were elevated in the children with pneumonia, and especially in those children who had lobar pneumonia and parapneumonic effusion. This may reflect that an acute lower respiratory tract infection can increase the production and release of VEGF. VEGF is known to be elevated in chronic lung diseases such as asthma and cystic fibrosis (7,8,14,15), whereas there are little data on its relationship with acute pneumonia (11), and furthermore, there is no data on CAP. In a study on acute eosinophilic pneumonia, the VEGF levels were measured in the bronchoalveolar lavage (BAL) fluids and its levels in the patients with acute eosinophilic pneumonia were higher than those VEGF levels of the control group, and the VEGF levels rapidly decreased to the control levels in parallel with the clinical improvement (11). Another clinical study showed that the serum VEGF levels were elevated in cystic fibrosis patients having acute exacerbations, and these levels were decreased with antibiotic therapy (14). These data support our results showing that the VEGF elevation is related to the airway inflammation associated with infection. On the contrary, in a study using lung autopsy material from septic patients, it was demonstrated that the pulmonary VEGF expression was decreased in the septic patients compared to that in the controls (16). Even though pneumonia, pulmonary edema and acute respiratory distress syndrome are the usual pulmonary manifestations during sepsis, the postmortem lung tissue seems to be different from the lung tissue seen in the acute infection states, and other factors such as mechanical ventilation, prolonged antibiotic use and a downhill clinical course to death will contribute to the confounding variables.
###end p 29
###begin p 30
###xml 401 422 401 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus aureus</italic>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 538 562 538 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus pneumoniae</italic>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 647 656 647 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. aureus</italic>
###xml 661 674 661 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 938 940 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 157 165 <span type="species:ncbi:9606">patients</span>
###xml 201 209 <span type="species:ncbi:9606">patients</span>
###xml 401 422 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 538 562 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 623 628 <span type="species:ncbi:9606">human</span>
###xml 647 656 <span type="species:ncbi:1280">S. aureus</span>
###xml 661 674 <span type="species:ncbi:1313">S. pneumoniae</span>
There have been no data that the serum VEGF level is related to the radiologic type of pneumonia. In this study, the serum levels of VEGF were higher in the patients with lobar pneumonia than in those patients with bronchopneumonia. It is not certain whether the VEGF elevation is related to the extent of inflammation or if it is related to the virulence of the microorganisms. In an in vitro study, Staphylococcus aureus stimulated VEGF release from the normal mesothelial cells in a dose-dependent and time-dependent pattern (17), and Streptococcus pneumoniae induced the dose- and time-dependent secretion of VEGF from human neutrophils (18). S. aureus and S. pneumoniae are two of the most common causes of severe, complicated pneumonia with parapneumonic effusion and empyema. There was no data on the association of the VEGF release with adenovirus infection, which can cause complicated pneumonia that mimics bacterial pneumonia (19).
###end p 30
###begin p 31
###xml 51 64 51 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 396 409 396 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 654 667 654 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 775 788 775 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 866 868 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 18 26 <span type="species:ncbi:9606">children</span>
###xml 51 64 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 124 132 <span type="species:ncbi:9606">children</span>
###xml 396 409 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 654 667 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 753 761 <span type="species:ncbi:9606">patients</span>
###xml 775 788 <span type="species:ncbi:1313">S. pneumoniae</span>
In our study, the children with a positive urinary S. pneumoniae antigen test showed higher levels of serum VEGF than those children with negative results for lobar pneumonia. We found that all the cases with positive urinary pneumococcal antigen tests were lobar pneumonia with or without parapneumonic effusion; and no bronchopneumonia cases were positive on this test. Even though the urinary S. pneumoniae antigen test alone cannot be a tool for the definitive diagnosis of pneumococcal infection, it can be used as a presumptive diagnostic method, especially in case of invasive pneumococcal infection (whether it is bacteremia or lobar pneumonia). S. pneumoniae is isolated from the blood or pleural fluid in only 10-30% of pneumococcal pneumonia patients. The urinary S. pneumoniae antigen test yields a sensitivity of 77-92% and a specificity of 97-100% (20-23).
###end p 31
###begin p 32
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
The level of VEGF has been shown to be consistently higher in the exudative pleural effusions than in the transudative pleural effusions (17,24-26). The empyema fluids also contain high levels of VEGF (24,27), which is up to five fold higher than the VEGF levels in the uncomplicated parapneumonic effusions (17). This study suggests that more complicated pneumonia which is usually caused by more virulent pathogens seems to be associated with a greater release of VEGF.
###end p 32
###begin p 33
###xml 348 349 348 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
We did not compare the serum VEGF levels with those VEGF levels in the BAL fluid or the pleural effusion. The relative contribution of local VEGF production in pneumonia and also in the parapneumonic effusion is not well known. It was reported that local production is the main source of VEGF in the effusions rather than diffusion from the serum (6) and VEGF is likely to originate from multiple cellular sources such as the residential mesothelial cells, the circulating inflammatory cells, and the infiltrating malignant cells within the pleural space (28). There was the correlation of VEGF with the monocyte and macrophage concentrations (29). It is thought that during acute infection such as bacterial pneumonia, the blood supply increases as the inflammation progresses and the inflammatory cells infiltrate into the inflamed tissue. As a result of the local VEGF production by the recruited inflammatory cells, as well as the VEGF production from the pulmonary epithelial cells, the endothelial cells and the smooth muscle cells, the vascular permeability increased; this in turn causes pulmonary edema or effusion. In the systemic circulation, these inflammatory cells produce VEGF, and this causes the elevation of the serum VEGF levels as well.
###end p 33
###begin p 34
###xml 415 428 415 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 64 72 <span type="species:ncbi:9606">patients</span>
###xml 134 142 <span type="species:ncbi:9606">patients</span>
###xml 182 190 <span type="species:ncbi:9606">patients</span>
###xml 222 230 <span type="species:ncbi:9606">patients</span>
###xml 259 267 <span type="species:ncbi:9606">patients</span>
###xml 347 355 <span type="species:ncbi:9606">patients</span>
###xml 382 390 <span type="species:ncbi:9606">children</span>
###xml 415 428 <span type="species:ncbi:1313">S. pneumoniae</span>
In this study, serum VEGF levels increased significantly in the patients with pneumonia compared to the controls, especially in those patients with lobar pneumonia compared to those patients with bronchopneumonia. For the patients with lobar pneumonia, those patients with parapneumonic effusion showed higher levels of serum VEGF compared to the patients without effusion, and the children with a positive urinary S. pneumoniae antigen test showed higher concentrations of serum VEGF compared to those with negative results.
###end p 34
###begin p 35
VEGF may be one of the key mediators that lead to more severe and complicated pneumonia; this can provide researchers with a new strategy for therapy in the future and so help in the prevention of severe and complicated pneumonia.
###end p 35
###begin article-title 36
New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases
###end article-title 36
###begin article-title 37
Parapneumonic effusion and pleural empyema; topical aspects of classification, diagnosis and treatment
###end article-title 37
###begin article-title 38
Vascular permeability factor/vascular endothelial growth factor - an important mediator of angiogenesis in malignancy and inflammation
###end article-title 38
###begin article-title 39
Molecular and biological properties of vascular endothelial growth factor
###end article-title 39
###begin article-title 40
Vascular endothelial growth factor and the regulation of angiogenesis
###end article-title 40
###begin article-title 41
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease
###end article-title 41
###begin article-title 42
Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis
###end article-title 42
###begin article-title 43
Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma
###end article-title 43
###begin article-title 44
###xml 134 142 <span type="species:ncbi:9606">patients</span>
Acute and chronic changes of vascular endothelial growth factor (VEGF) in induced sputum of toluene diisocyanate (TDI)-induced asthma patients
###end article-title 44
###begin article-title 45
Vascular endothelial growth factor levels in active pulmonary tuberculosis
###end article-title 45
###begin article-title 46
Increased vascular endothelial growth factor in acute eosinophilic pneumonia
###end article-title 46
###begin article-title 47
###xml 24 32 <span type="species:ncbi:9606">patients</span>
Angiogenic cytokines in patients with idiopathic interstitial pneumonia
###end article-title 47
###begin article-title 48
###xml 38 46 <span type="species:ncbi:9606">children</span>
Vascular endothelial growth factor in children with lower respiratory tract disease
###end article-title 48
###begin article-title 49
Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation
###end article-title 49
###begin article-title 50
Angiogenesis and remodeling of airway vasculature in chronic inflammation
###end article-title 50
###begin article-title 51
Pulmonary expression of vascular endothelial growth factor in sepsis
###end article-title 51
###begin article-title 52
Bacterial induction of pleural mesothelial monolayer barrier dysfunction
###end article-title 52
###begin article-title 53
###xml 0 24 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 84 89 <span type="species:ncbi:9606">human</span>
Streptococcus pneumoniae induces secretion of vascular endothelial growth factor by human neutrophils
###end article-title 53
###begin article-title 54
###xml 76 84 <span type="species:ncbi:9606">children</span>
Lower respiratory tract infections due to adenovirus in hospitalized Korean children: epidemiology, clinical features, and prognosis
###end article-title 54
###begin article-title 55
Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults
###end article-title 55
###begin article-title 56
###xml 82 90 <span type="species:ncbi:9606">patients</span>
Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia
###end article-title 56
###begin article-title 57
###xml 87 111 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation
###end article-title 57
###begin article-title 58
###xml 96 104 <span type="species:ncbi:9606">children</span>
Evaluation of a rapid urine antigen assay for the detection of invasive pneumococcal disease in children
###end article-title 58
###begin article-title 59
Vascular endothelial growth factor in pleural fluid
###end article-title 59
###begin article-title 60
Vascular endothelial growth factor level correlates with transforming growth factor beta isoform levels in pleural effusions
###end article-title 60
###begin article-title 61
Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer
###end article-title 61
###begin article-title 62
Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions
###end article-title 62
###begin article-title 63
Vascular endothelial growth factor: the key mediator in pleural effusion formation
###end article-title 63
###begin article-title 64
###xml 69 79 <span type="species:ncbi:10141">guinea pig</span>
###xml 84 89 <span type="species:ncbi:9606">human</span>
Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions
###end article-title 64
###begin p 65
###xml 214 215 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 491 492 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 126 134 <span type="species:ncbi:9606">children</span>
###xml 374 382 <span type="species:ncbi:9606">children</span>
###xml 459 467 <span type="species:ncbi:9606">children</span>
(A) Comparison of the serum VEGF concentrations between the pneumonia and control groups. Serum concentrations of VEGF in the children with pneumonia are much higher than those VEGF levels in the control subjects (p<0.01). (B) Comparison of the serum VEGF concentrations according to the types of pneumonia on the basis of the chest radiographs. The serum levels of VEGF in children with lobar pneumonia are significantly higher than those VEGF levels in the children with bronchopneumonia (p<0.01).
###end p 65
###begin p 66
###xml 164 177 164 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 312 325 312 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 423 436 423 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. pneumoniae</italic>
###xml 451 452 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 56 64 <span type="species:ncbi:9606">children</span>
###xml 120 128 <span type="species:ncbi:9606">children</span>
###xml 164 177 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 258 266 <span type="species:ncbi:9606">children</span>
###xml 312 325 <span type="species:ncbi:1313">S. pneumoniae</span>
###xml 423 436 <span type="species:ncbi:1313">S. pneumoniae</span>
Comparison of the serum VEGF concentrations between the children with and without pleural effusion (A), and between the children with positive and negative urinary S. pneumoniae antigen tests (B) in the lobar pneumonia group. The serum levels of VEGF in the children with pleural effusion and a positive urinary S. pneumoniae antigen test are significantly higher than those without pleural effusion and a negative urinary S. pneumoniae antigen test (p<0.05).
###end p 66
###begin p 67
###xml 117 125 <span type="species:ncbi:9606">children</span>
Correlation of the serum VEGF concentrations with the acute inflammatory parameters. (A) Serum levels of VEGF in the children with pneumonia show positive correlation with the erythrocyte sedimentation rate (ESR). (B, C) Serum levels of IL-6 and C-reactive protein (CRP) show no significant correlations with the serum VEGF levels.
###end p 67
###begin p 68
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient profiles and laboratory findings in each group
###end p 68
###begin p 69
Data are presented as mean+/-SEM. N.D, Not done.
###end p 69
###begin p 70
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 37 43 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 96 109 91 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8225;</sup>
###xml 109 110 92 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 200 212 183 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#167;</sup>
###xml 212 213 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*p<0.05 compared with control group; daggerUrine streptococcal pneumonia antigen test positive; double daggerp<0.05 compared with lobar pneumonia, and bronchopneumonia without pleural effusion group; section signp<0.05 compared with bronchopneumonia without pleural effusion group.
###end p 70

